Week 1: April 10-15, 2021
Week 2: May 17-21, 2021
Poster #1587, Session PO.IM02.02 - Combination Immunotherapies: "Generation and characterization of novel bispecific molecules combining single-chain-CD40L with anti-CEA, anti-CD95L or anti-PD-L1 targeting moieties"
Authors: Matthias Schroeder, Katharina Billian-Frey, Jaromir Sykora, Mauricio Redondo-Mueller, Karl Heinonen, Jamie Frankish, Christian Gieffers, Meinolf Thiemann, Oliver Hill
Presentations and Posters from Past Conferences
June 22-24, 2020
Presentation #1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies